Free Trial
NASDAQ:SIBN

SiBone Q2 2025 Earnings Report

SiBone logo
$17.39 +0.36 (+2.11%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$17.38 -0.01 (-0.06%)
As of 08/1/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SiBone EPS Results

Actual EPS
N/A
Consensus EPS
-$0.19
Beat/Miss
N/A
One Year Ago EPS
N/A

SiBone Revenue Results

Actual Revenue
N/A
Expected Revenue
$48.12 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

SiBone Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Monday, August 4, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

SiBone Earnings Headlines

This Crypto Is Set to Explode in January
This Could Be the Most Important Crypto Law in History While the world celebrates Bitcoin becoming 2025’s top-performing asset, smart hedge funds are accumulating elsewhere. During the upcoming Crypto Hedge Fund Summit, you'll discover exactly which coins they’ve loaded up on before this historic vote.
See More SiBone Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like SiBone? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SiBone and other key companies, straight to your email.

About SiBone

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

View SiBone Profile

More Earnings Resources from MarketBeat